Publication date: Jul 23, 2024
To report a case of uveal effusion syndrome in association with primary COVID-19 infection to share our experience and insight in diagnosing and managing this unique case. A 56-year-old woman presented with angle closure glaucoma of both eyes. Further examination and imaging revealed the etiology to be related to bilateral uveal effusions and choroidal thickening in the setting of recent COVID-19 infection. The patient’s glaucoma was managed with bilateral iridotomies and medical therapy, while the precipitating uveal effusions resolved with treatment on oral steroids. While uveal effusion syndrome has been associated with COVID-19 vaccination, it has not yet been reported after primary infection. Recognition of this rare phenomenon will allow for better diagnosis and treatment in future cases.
| Concepts | Keywords |
|---|---|
| Choroidal | Angle-closure glaucoma |
| Covid | choroid |
| Old | COVID-19 |
| Vaccination | oral steroids |
| Woman | uveal effusion syndrome |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Uveal Effusion Syndrome |
| disease | MESH | COVID-19 |
| disease | MESH | Infection |
| disease | VO | report |
| disease | MESH | angle closure glaucoma |
| disease | MESH | etiology |
| disease | MESH | glaucoma |
| disease | VO | vaccination |
| disease | IDO | primary infection |
| drug | DRUGBANK | Tropicamide |
| disease | MESH | Long Covid |